Quick Answer
TransMedics Group, Inc. reported Long Term Debt of $58.70 million for the year ending 2022.
- TransMedics Group, Inc. showed an increase of +66.8% in Long Term Debt from 2021 to 2022.
- This data is from TransMedics Group, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2023.
- XBRL data for this metric is available from 2018 to 2022 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $33.79 million | Q2 2019: $33.90 million | Q3 2019: $34.02 million | Q1 2020: $34.27 million | Q2 2020: $34.40 million | Q3 2020: $34.53 million | Q1 2021: $34.79 million | Q2 2021: $34.92 million | Q3 2021: $35.06 million | Q1 2022: $35.33 million | Q2 2022: $35.48 million | Q3 2022: $58.54 million | Q4 2022: $58.70 million | Q1 2023: $58.80 million.
- Over the full 5 years of available data (2018 to 2022), TransMedics Group, Inc.'s Long Term Debt has grown by 74.3%.
- Historical annual values: Fiscal year 2022: $58.70 million | Fiscal year 2021: $35.20 million | Fiscal year 2020: $34.66 million | Fiscal year 2019: $34.15 million | Fiscal year 2018: $33.67 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: